NO20080314L - Bicykliske 6-alkyliden-penem B-laktamase inhibitorer og B-laktam antibiotisk kombinasjon: et bred spektret antibiotika - Google Patents

Bicykliske 6-alkyliden-penem B-laktamase inhibitorer og B-laktam antibiotisk kombinasjon: et bred spektret antibiotika

Info

Publication number
NO20080314L
NO20080314L NO20080314A NO20080314A NO20080314L NO 20080314 L NO20080314 L NO 20080314L NO 20080314 A NO20080314 A NO 20080314A NO 20080314 A NO20080314 A NO 20080314A NO 20080314 L NO20080314 L NO 20080314L
Authority
NO
Norway
Prior art keywords
penem
alkylidene
bicyclic
antibiotics
lactam antibiotic
Prior art date
Application number
NO20080314A
Other languages
English (en)
Norwegian (no)
Inventor
Aranapakam Mudumbai Venkatesan
Tarek Suhayl Mansour
Peter James Petersen
Patricia Ann Bradford
Steven J Projan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20080314L publication Critical patent/NO20080314L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20080314A 2005-07-27 2008-01-18 Bicykliske 6-alkyliden-penem B-laktamase inhibitorer og B-laktam antibiotisk kombinasjon: et bred spektret antibiotika NO20080314L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70280905P 2005-07-27 2005-07-27
PCT/US2006/028948 WO2007016134A1 (en) 2005-07-27 2006-07-26 BICYCLIC 6-ALKYLIDENE-PENEM B-LACTAMASE INHIBITORS AND β-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC

Publications (1)

Publication Number Publication Date
NO20080314L true NO20080314L (no) 2008-04-22

Family

ID=37110353

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080314A NO20080314L (no) 2005-07-27 2008-01-18 Bicykliske 6-alkyliden-penem B-laktamase inhibitorer og B-laktam antibiotisk kombinasjon: et bred spektret antibiotika

Country Status (18)

Country Link
US (1) US20070129344A1 (OSRAM)
EP (1) EP1906954A1 (OSRAM)
JP (1) JP2009502934A (OSRAM)
KR (1) KR20080032637A (OSRAM)
CN (1) CN101232881A (OSRAM)
AR (1) AR055096A1 (OSRAM)
AU (1) AU2006275940A1 (OSRAM)
BR (1) BRPI0613927A2 (OSRAM)
CA (1) CA2615886A1 (OSRAM)
CR (1) CR9691A (OSRAM)
EC (1) ECSP088132A (OSRAM)
GT (1) GT200600331A (OSRAM)
IL (1) IL188843A0 (OSRAM)
NO (1) NO20080314L (OSRAM)
PE (1) PE20070403A1 (OSRAM)
RU (1) RU2008102912A (OSRAM)
TW (1) TW200727897A (OSRAM)
WO (1) WO2007016134A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
US20090018332A1 (en) * 2007-06-28 2009-01-15 Wyeth Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors
CN103435617B (zh) * 2013-08-22 2016-04-27 南京华安药业有限公司 一种6,7-二氢-5H-吡咯并[1,2-a]咪唑-2-甲醛的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206067A (en) * 1978-10-02 1980-06-03 Chevron Research Company Thermally stabilized erosion-inhibited functional fluids containing perhalometal compounds and an organic base
EP0041768B1 (en) * 1980-04-24 1987-11-11 Beecham Group Plc Beta-lactam compounds, their preparation and use
US4891369A (en) * 1986-12-03 1990-01-02 Taiho Pharmaceutical Company, Limited 2β-Substituted-methylpenicillanic acid derivatives, and salts and esters thereof
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
WO1995028935A1 (en) * 1994-04-25 1995-11-02 Smithkline Beecham Plc Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
EA200100347A1 (ru) * 1998-10-15 2001-10-22 Саравак Медичем Фармасьютикалс, Инк. Метод и композиция для лечения и профилактики туберкулеза
GB9928290D0 (en) * 1999-12-01 2000-01-26 Univ Belfast Process for preparing ambient temperature ionic liquids
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR046041A1 (es) * 2003-10-03 2005-11-23 Aventis Pharma Inc Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos

Also Published As

Publication number Publication date
GT200600331A (es) 2007-02-26
BRPI0613927A2 (pt) 2011-02-15
CR9691A (es) 2008-04-02
KR20080032637A (ko) 2008-04-15
JP2009502934A (ja) 2009-01-29
TW200727897A (en) 2007-08-01
CN101232881A (zh) 2008-07-30
PE20070403A1 (es) 2007-05-15
ECSP088132A (es) 2008-03-26
US20070129344A1 (en) 2007-06-07
IL188843A0 (en) 2008-08-07
RU2008102912A (ru) 2009-09-10
WO2007016134A9 (en) 2009-03-12
EP1906954A1 (en) 2008-04-09
AR055096A1 (es) 2007-08-08
CA2615886A1 (en) 2007-02-08
WO2007016134A1 (en) 2007-02-08
AU2006275940A1 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
NO20074703L (no) Antibakterielle piperidinderivater
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
AU2003268156A1 (en) Novel pyrazolopyridine derivatves as pharmaceutical agents
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
EA201001368A1 (ru) Гетероциклические производные мочевины и способы их применения-211
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
CY1112167T1 (el) Νεα χρηση αντιβιοτικων κινολονης
NO20073259L (no) Nye 4-arylaminopyndondenvater som MEK inhibrtorer av hyperproliferende lidelser
EA200400086A1 (ru) Новые производные оксазолидинонов в качестве антибактериальных агентов
EA201001858A1 (ru) Гетероциклические производные мочевины для лечения бактериальных инфекций
EA201001859A1 (ru) Гетероциклические производные мочевины и способы их применеия
NO20044550L (no) Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer
WO2006120563A3 (en) Antibacterial agents
UY28542A1 (es) Amidas macrocíclicas antibacterianas
ECSP088132A (es) INHIBIDORES DE 6-ALQUILIDENO-PENEME B-LACTAMASA BICÍCLICOS Y COMBINACIÓN ANTIBIÓTICA DE ß-LACTAMA: UN ANTIBIÓTICO DE AMPLIO ESPECTRO
NO20074167L (no) Peptidiske forbindelser
WO2006087544A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
WO2006093933A3 (en) Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
DE502005010850D1 (de) Antibakterielle amid-makrozyklen iv
WO2007027323A3 (en) TRICYCLIC 6-ALKYLIDENE-PENEM β-LACTAMASE INHIBITORS AND β-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC
MX2010014248A (es) Nuevos antibioticos de trinem e inhibidores de beta-lactamasas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application